Claudine Q. Homolash Comments on Status of Topamax Litigation
Plaintiff’s attorney Claudine Q. Homolash opines on the current status of the Topamax litigation against Johnson & Johnson pending in the Philadelphia Court of Common Pleas. The drug Topamax has been linked to the development of Cleft Lip and/or Cleft Palate in newborns. The Risperdal gynecomastia cases are also filed in the Philadelphia Court of Common Pleas against the drug manufacturer Johnson & Johnson. Ms. Homolash has experience litigating cases against Johnson & Johnson.
Read Ms. Homolash’s comments here:
Claudine Q. Homolash Esq. is a highly experienced drug injury and defective medical device lawyer. Ms. Homolash represents plaintiffs across the country and has offices in Philadelphia PA. Contact email@example.com or 1-(844) 677-4276 or (215) 496-1012 for a free legal consultation.